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whether active follow-up by serial imaging is justified and how planned imaging will impact clinical deci-
sion making in absence of clinical progression. Methods: We included all consecutive patients with BSCM
treated and followed at our Department between 2006 and 2018. Results: Of 429 patients with CCM,
118 were diagnosed with BSCM (27.5%). Patients were followed for a mean of 8.1 (± 7.4 SD) years.
Conservative treatment was recommended in 54 patients over the complete follow-up period, whereas 64
patients underwent surgical extirpation of BSCM. In total, 75 surgical procedures were performed. Over
a period of 961 follow-up years in total, routinely performed follow-up MRI in clinically stable patients
did not lead to a single indication for surgery. Conclusion: Due to the difficult-to-predict clinical course
of patients with BSCM and the relatively high risk associated with surgery, routine imaging is unlikely
to have any influence on surgical decision making in clinically stable patients with BSCM.
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Background: Clinical management of patients with brainstem cavernous malformations
(BSCM) is often challenging due to the unpredictable clinical course and lack of
high-quality evidence. Nevertheless, radiologic follow-up is often performed routinely.
The objective of this work was to investigate whether active follow-up by serial imaging
is justified and how planned imaging will impact clinical decision making in absence of
clinical progression.
Methods: We included all consecutive patients with BSCM treated and followed at our
Department between 2006 and 2018.
Results: Of 429 patients with CCM, 118 were diagnosed with BSCM (27.5%). Patients
were followed for a mean of 8.1 (± 7.4 SD) years. Conservative treatment was
recommended in 54 patients over the complete follow-up period, whereas 64 patients
underwent surgical extirpation of BSCM. In total, 75 surgical procedures were performed.
Over a period of 961 follow-up years in total, routinely performed follow-upMRI in clinically
stable patients did not lead to a single indication for surgery.
Conclusion: Due to the difficult-to-predict clinical course of patients with BSCM and
the relatively high risk associated with surgery, routine imaging is unlikely to have any
influence on surgical decision making in clinically stable patients with BSCM.
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INTRODUCTION
Cerebral cavernous malformations (CCM) are among the most common vascular lesions of
the central nervous system (CNS). While a majority of CCM are located supratentorially, a
significant subset comprising ∼15–18% of all intracranial CCM affect the brainstem (1). The
clinical management of brainstem cavernous malformations (BSCM) poses a particular challenge.
Given the highly eloquent anatomy with high density of cranial nerve nuclei and fiber tracts
within the brainstem, even small BSCM hemorrhages can cause severe neurological symptoms.
Furthermore, BSCM are associated with an increased risk of hemorrhage compared to CCM
in other locations (1–3). It is unknown whether this is due to the fact that CCM hemorrhages
that cause significant symptomatology in the brainstem would go unnoticed in an ineloquent
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supratentorial location, implying that supratentorial CCM
hemorrhages are underdiagnosed relative to those in the
brainstem. In any case, it is known that especially recurrent
BSCM hemorrhages often create a pattern of progressive
neurological decline, with most patients never returning to their
prehemorrhage baseline (2, 4).
Risk assessment with regard to morbidity and mortality is
essential to balance the risk of surgery against the natural history
of BSCM when deciding whether or not to offer surgery. The
decision to recommend surgery is difficult and depends on
a number of factors such as patient presentation, lesion size,
accessibility, distance to the pial or ependymal surface, history
of repetitive hemorrhage and surgeon expertise, among others.
However, assessing and discussing the indication for surgical
treatment of BSCM is beyond the scope of the manuscript (1–3).
In cases of unclear distinction of BSCM from that of BSCM
mimics due to initial acute brainstem hemorrhage, follow-up
MRI within 3 months is recommended to confirm the diagnosis
of BSCM (5–7).
As the clinical course of patients with BSCM is unpredictable
and high-quality evidence is lacking, it is unclear whether or
not active, serial clinical and radiological follow-up should be
recommended in the further course. Currently, indication and
timing of follow-up imaging in patients with BSCM is likely based
on individual judgment.
Given the lack of literature on follow-up strategies for patients
with BSCM (8), the objective of this study was to critically address
whether serial follow-up imaging in clinically stable patients with
BSCM is justified and how frequently imaging will influence
clinical decision making in these cases.
MATERIALS AND METHODS
Study Design and Patient Population
The present work is an observational, retrospective single-center
study encompassing all patients with CCM that presented to
our institution between 2006 and 2018. Inclusion criteria were
as follows: Radiological or histological diagnosis of BSCM (1)
and availability of follow-up data (2). Diagnosis of BSCM was
confirmed by a board-certified neuroradiologist on imaging, and
histologically by a board-certified neuropathologist when tissue
was available for analysis.
Data Collection
The medical history of each patient was analyzed for age, gender
and clinical symptoms. In addition, date of first diagnosis,
date of first contact to any neurosurgical department, date
of last follow-up, as well as the number and dates of MRI-
studies were collected. MRI-studies always comprised at least
T1-weighted imaging (with and without contrast enhancement),
T2-weighted imaging, and gradient echo sequences in all
three planes (axial, coronal and sagittal) or susceptibility-
weighted imaging (SWI). The dates and indications for each
Abbreviations: BSCM, Brainstem cavernous malformations; CCM, cerebral
cavernous malformations; cMRI, cerebral magnetic resonance imaging; CNS,
central nervous system; KPS, Karnofsky Performance Scale; mRS, modified Rankin
Scale; NIHSS, National Institutes of Health Stroke Scale.
surgical intervention were obtained, as was the type of patient
contact—being elective (outpatient consultation), referral to
our institution for second opinion, or emergency (in-patient
consultation/emergency room).
Patient Management
At our department, we tend to recommend conservative
management to patients with BCSM in absence of severe
neurological deficits, and we restrain from operating after the
first hemorrhage or when spontaneously improving neurological
deficits occur. In cases of recurrent BSCM hemorrhage surgical
treatment is further evaluated and discussed.
We perform routine radiological and clinical follow-up 6
months after initial diagnosis of BSCM and yearly in patients with
known BSCM, comprising both MRI studies and consultation
with a specialized neurosurgeon.
Statistical Analysis
Descriptive statistical analysis was performed with IBM SPSS
Statistics version 20.0 (IBM Corp., Armonk, New York, USA).
RESULTS
Study Population and Patient
Demographics
Four hundred and twenty-nine patients with CCM were seen at
our institution between 2006 and 2018. Of those, n= 118 (27.5%)
patients harbored BSCM, fulfilled the above-mentioned criteria
for this study and were included in the analysis (Figure 1). The
mean age at first diagnosis was 41.1 years (± 17.11 SD; range
7.46–84.64); 44.9% of the patients were male (Table 1). The
mean follow-up was 8.1 (±7.4 SD) years per patient. The total
follow-up time was 961 person-years.
Clinical Management—Conservative and
Operative Group
Conservative treatment was performed in 54 patients, while 64
patients underwent surgical resection of the BSCM (Figure 1).
In the conservatively treated patient cohort, 17 patients (31.5%)
stayed free of symptoms during FU, whereas 37 patients (68.5%)
presented with neurological deficits. BSCMhemorrhage occurred
in 41 (75.9%), whereas in 13 patients (24.1%) no BSCM
hemorrhage was observed. During follow-up, an increase of size
of the BSCMwas radiologically confirmed in 15 patients (27.8%).
Among the 64 patients, 75 surgical procedures related to
BSCM were performed in total, including 10 patients having
undergonemultiple surgeries. Two surgeries were performed due
to the BSCM but without the aim of surgically resecting the
BSCM (1 third ventriculocisternostomy, 1 external ventricular
drain placement). In 9 instances, multiple surgeries were
performed due to previously incompletely resected BSCM.
Surgery was performed within 3 months after initial diagnosis
of BSCM in 38 patients, and at later stages of follow-up (>3
months) in 26 patients.
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FIGURE 1 | Analyzed patient cohort: From 429 patients with CCM, n = 118 (27.5%) patients harbored BSCM; in n = 64 surgical treatment was performed, whereas
in n = 54 patients conservative treatment was performed. Seventy-five surgical interventions were performed in total.
Surgical Intervention Due to (Recurrent)
BSCM Hemorrhage
Among the 64 patients that had undergone surgery, in 62 patients
(96.8%) indication for surgical extirpation of the BSCMwas done
based on no-routine imaging that was performed in the context
of clinical worsening (based on the KPS, mRS and NIHSS) as a
direct consequence of BSCM (recurrent) hemorrhage.
In two patients, BSCM diagnosis was made and follow-
up performed abroad. In both cases BSCM resection was
not performed due to the lack of surgical experience at
the institution where the patient was initially treated.
Thus, surgery was deferred and in the patients were
followed-up including routinely performed imaging
studies. After continuous clinical deterioration due to the
recurrent BSCM hemorrhage, the patients were ultimately
referred to our Department of Neurosurgery where
microsurgical removal of the BSCM was performed after
the first consultation.
Impact of Planned Follow-Up Imaging on
Surgical Decision Making
During 961 follow-up years of 118 patients with BSCM, routinely
performed follow-up MRI in clinically stable (= no clinical
worsening based on the KPS, mRS and NIHSS) patients did not
lead to a single indication for surgery.
DISCUSSION
The clinical course of patients with BSCM is difficult to
predict and high quality evidence on follow-up management
of BSCM is lacking (9). To date, there is no consensus on
the best management for BSCM. The aim of this study was
therefore to critically appraise the clinical management of
patients with BSCM.
Currently, indication and timing of follow-up imaging in
this patient population is highly individualized as relatively
little convincing data is available to make evidence-based
recommendations. Clinical management of patients with BSCM
is thus largely based on the treating physician’s subjective
judgement, which aims at integrating relevant factors such
as a patient’s quality of life, size and location of the BSCM,
previous hemorrhages and patient preference to make treatment
recommendations. In the absence of indication for immediate
surgical intervention, the two strategies most frequently pursued
involve either active follow-up and serial imaging on a regular
basis, or performing imaging studies only with new onset
of suggestive symptoms such as atypical headache or new
neurological deficit (8, 10). Independent of the specific approach
recommended, patients should be treated at a neurosurgical
referral center with experience in the clinical management of
BSCM, given the rarity of BSCM and the complexity of its
management (11).
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TABLE 1 | Baseline patient characteristics.
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Follow-up time in years (mean ± SD) 8.1 7.4
Based on general recommendations for patients with CCM
(8), we have typically performed routine follow-up imaging
to monitor growth dynamics or asymptomatic hemorrhages in
patients with BSCM at our institution. However, as there are
no predictive models available for BSCM, it is unclear which
radiographic changes predict a clinical course where immediate
or early surgery is superior to conservative management
with regard to clinical outcome. We hypothesized that, as a
consequence, routine follow-up imaging will only lead to the
decision to surgically treat the patient in very rare cases, if any.
In the cohort of 118 patients with BSCM treated at our
institution a slight majority (54.2%) underwent surgery during
a total of 961 years, whereas 46.8% were treated conservatively.
Of the 64 patients that were surgically treated for BSCM,
in the overwhelming majority (96.8%) indication for surgery
was done based on non-routine imaging that was performed
in the context of new or progressive symptoms due to BSCM
hemorrhage. Two patients, which were initially treated abroad,
BSCM resection was not performed at the respective institution
due to the lack of surgical experience. Ultimately, both patients
underwent surgery after clinical deterioration and subsequent
referral to our department. Therefore, during 961 follow-up years
of 118 patients with BSCM, routinely performed follow-up MRI
in clinically stable patients did not lead to a single indication
for surgery.
The methodological limitations of retrospective and single-
center cohorts, the heterogenous patient cohort and the lack
of previously defined endpoints regarding clinical outcome
represent significant limitations to this study. While the design
of the present study does not allow for conclusions regarding
the adequacy of the treatment decisions made, it can be clearly
stated that the impact of routine follow-up imaging is very
limited. These findings are in line with another study recently
published by our group. There, we addressed the question
whether routinely performed imaging had an impact on surgical
decision making in patients with multiple CCM and found that
it is highly questionable as there is no evidence for therapeutic
relevance (12).
In general, it is likely a reasonable strategy to avoid imaging
studies in absence of a clear indication. While the imaging
process in and of itself can already cause discomfort and
be inconvenient to patients, cost-effectiveness will become
increasingly important in the context of rising healthcare costs
and financial pressure. Avoiding relatively expensive imaging
studies with unclear value regarding decision-making may be
an attractive option to reduce healthcare spending without
impairing the quality of patient care. However, a prospective
study with a large number of patients is warranted to confirm
our results.
Furthermore, although generally considered safe, repeated use
of gadolinium-based contrast-enhancing agents has been linked
to MRI signal changes and deposition of gadolinium in the brain
(13). While the clinical significance of these deposits remains
unclear, the fact that repeat contrast-enhanced imaging is indeed
associated with measurable changes provides an additional
rationale tominimize the number ofMRI performed on a patient.
Another important aspect to consider is the impact of routine
follow-up imaging on patients‘ psychology. It is conceivable that
many patients may prefer not to be reminded of their diagnosis
on a regular basis if there is no therapeutic consequence to the
regular follow-up visits. On the other hand, it is possible that
some patients would value the certainty of knowing on a regular
basis that the CCM has not grown, especially those patients that
had previously undergone routine follow-up imaging for many
years. Regular follow-up consultation visits focusing on clinical
evaluation without imaging studies could be a reasonable option
to strike a balance between routinely performed imaging and
no follow-up visits at all. In any case, careful patient education
and inclusion of the patient in the decision process will allow
the treating physician to individually tailor the treatment plan to
the patient.
CONCLUSION
Routinely performed imaging in clinically stable patients with
brainstem cavernoma had no impact on surgical decision making
in this series. Therefore, it appears reasonable to limit clinical
management to patient education and symptom-driven follow-
up strategy.
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